New figures from the Medicines and Healthcare products Regulatory Agency (MHRA) show the group of drugs that includes ...

To address this, researchers tested a new strategy: combining semaglutide (the active ingredient in Ozempic and Wegovy) with an experimental drug called bimagrumab. Bimagrumab is a lab-made antibody ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a new study into GLP-1 medicines after worrying ...

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

DALLAS — With the active ingredient behind such popular weight-loss medications as Ozempic and Wegovy no longer listed on the FDA's national drug shortage list, North Texas pharmacies are suddenly ...

Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...

Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...

Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.

Eli Lilly (NYSE: LLY) has been on fire over the past two years. The drugmaker has generated excellent financial results and ...